Alveo Technologies and UTMB have partnered to develop point-of-care diagnostics for Lassa fever, deploying molecular sensing platforms at clinical sites in Nigeria and Sierra Leone to support real-time pathogen detection.
A multicenter trial published in Clinical Chemistry reports Vitestro’s autonomous robotic phlebotomy system achieved a 94.5% first-stick success rate across 1,633 patients in routine clinical settings.
RNA-based testing improves detection of MET exon 14 skipping in NSCLC, identifying mutations missed by DNA-only assays, according to new research. Findings may impact eligibility for targeted therapies.
The collaboration aims to provide laboratories with a scalable alternative to traditional configuration models.
A new study presented at ADLM 2026 shows a high-sensitivity biosensor can quantify the ESAT-6 protein in blood, distinguishing active tuberculosis from latent infection and other lung diseases.
